Navigation Links
ViGene Biosciences Introduces World's Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
Date:11/6/2013

Of the 19,000 unique genes (loci) in the human genome, we have systematically generated 18,000 full-length cDNA templates representing 18000 unique loci. Each of these cDNAs will be cloned into our adenoviral vector to produce ready-to-use adenoviruses." noted Dr. Chen. "We are thrilled to have this near-complete genome-wide premade adenovirus collection. It will greatly accelerate genome-wide high throughput drug screening and development, cell-based assays, and many aspects of gene function studies."

In addition to the adenoviral vectors, ViGene has also developed lentiviral and adeno-associated viral (AAV) vectors. Upon completion of the genome-wide adenovirus production, ViGene is excited to further transfer the same set of full-length cDNA ORFs into lentiviral vector and AAV vector to create an even broader premade virus collection. ViGene's largest premade virus collection will represent the next generation gene products for advancing life science research.

About ViGene Biosciences

Based in Rockville, Maryland, ViGene Biosciences, Inc., is a genomics tool company that develops cutting-edge and next generation life science research reagents to support high-throughput drug discovery and functional genomics.  Pioneering the development of quality adenovirus and other viral vector production, ViGene features the world's largest collection of human full-length cDNA ORF clones, miRNA clones, premade cDNA ORF and miRNA adenoviruses, and top-of-the-line custom services.  ViGene is committed to its mission "Quality Is Our Business," for providing the highest quality products, services and bringing the most innovative ideas for gene based research.For more information, please visit www.vigenebio.com or contact ViGene by email at info@vigenebio.com or call (301)-231-0600

Media Contact: Kevin Lee, ViG
'/>"/>

SOURCE ViGene Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Electrophysiologist Kevin Makati, M.D. with St. ... Boston, MA to speak about ... Society conference. These scientific sessions drew more than ... people and technology that propel their specialty forward. ... invasive cardiac operation that combines the expertise of ...
(Date:5/22/2015)...  The U.S. Food and Drug Administration,s (FDA) ... biosimilar product approved in the United ... the contract manufacturing organization (CMO) industry, according to ... to the production of small-molecular drugs and lacks ... healthcare market research publisher,s report, Biopharmaceutical and ...
(Date:5/22/2015)... , May 22, 2015 According ... Market by Product (Consumables, Instruments, Services), by Test Type ... Chromatography, Flow Cytometry), by End Users - Global Forecast ... Market is expected to reach $736.85 Million by 2020 ... of 10.25%. Browse 71 market data ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... research at SRI International, scientists evaluating new drug targets against ... that could rapidly eliminate infections and potentially shorten treatment time. ... B, found in bacteria that cause TB infections. ... A and gyrase B. Although gyrase A is often the ...
... 29, 2011   Acuo Technologies ® ... for intelligent medical image lifecycle management and data ... has selected the Universal Clinical Platform (UCP3) ... UCP3 will replace Fairview,s existing PACS archives while ...
Cached Medicine Technology:SRI Researchers Validate Preclinical Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time 2Acuo Technologies Announces Vendor Neutral Archiving Contract with Fairview Health Services 2Acuo Technologies Announces Vendor Neutral Archiving Contract with Fairview Health Services 3
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... Liverpool, OH (PRWEB) May 22, 2015 ... announced that Kyle Johnson, the health system’s Chief Financial ... other interests. Johnson has served as the company CFO ... Wesley West will be joining the health system as ... on an interim basis, while the Board of Trustees ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... 2015 Carnegie Science Center ... a new partnership to develop BodyTech, a dynamic, three-pronged ... initiative includes a new exhibit at the Science Center ... and a new traveling science show, Anatomy Adventure, which ... , Designed to explore a wide range of ...
(Date:5/22/2015)... Power Systems is proud to announce the ... season. Drobeck is in his second year of racing in ... the Missoula Fire Department in Missoula, MT. He entered the ... During his career, he has had 15 1st Place finishes. ... 10 finishes in all seven of his 2014 races, including ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... Scientists at the ,University of North Carolina at Chapel ... plays a central role in the formation of new blood ... new blood vessel formation, or angiogenesis, is seriously impaired without ... 2011 in the journal Blood , was led by ...
... prevention trial that has been evaluating two antiretroviral (ARV)-based approaches ... daily use of one of two different ARV tablets or ... The decision to discontinue use of the gel, which contains ... study data concluded tenofovir gel was not effective in preventing ...
... -- Patients hospitalized for autoimmune disorders, like rheumatoid arthritis ... life-threatening pulmonary embolism, a clot in a main artery of ... 25 in The Lancet , researchers warned that steps ... to the hospital for autoimmune diseases. , , In conducting ...
... CHICAGO By combining conventional medical imaging with some ... blockbusters, researchers are offering new hope to victims of ... human face transplantation, led by Darren M. Smith, M.D., ... Center (UPMC), were presented today at the annual meeting ...
... News) -- Racism is similar to trauma in how ... the United States, a new analysis finds. An ... 18,000 black adults concluded that there are common responses ... that is expressed as physical pain), interpersonal sensitivity and ...
... should be able to choose where they give birth, concludes ... first-time mums who opt for a home birth are at ... low in all birth settings. The researchers say their ... pregnancies a choice of birth setting" and will enable women ...
Cached Medicine News:Health News:Cell molecule identified as central player in the formation of new blood vessels 2Health News:Cell molecule identified as central player in the formation of new blood vessels 3Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 2Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 3Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 4Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 5Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 6Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 7Health News:Autoimmune Woes May Raise Risk for Lung Clots 2Health News:Integrated 3-D imaging facilitates human face transplantation 2Health News:Integrated 3-D imaging facilitates human face transplantation 3Health News:Pregnant women at low risk of complications can safely be offered a choice of where to give birth 2
Stainless steel bone clamp....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
Straight double action bone cutting rongeur....
Beuse Zygomatic Arch Awl with slightly curved tip....
Medicine Products: